| scholarly article | Q13442814 |
| P2093 | author name string | Eduardo Bonilla | |
| Rabi Tawil | |||
| Salvatore Di Mauro | |||
| Michelangelo Mancuso | |||
| Guido Davidzon | |||
| James M Powers | |||
| Roger M Kurlan | |||
| P2860 | cites work | Oxygen toxicity, oxygen radicals, transition metals and disease | Q29615096 |
| Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease | Q34083035 | ||
| Carbon Monoxide: a Putative Neural Messenger | Q34305648 | ||
| Pathogenesis of primary defects in mitochondrial ATP synthesis. | Q34458270 | ||
| Neuroferritinopathy in a French family with late onset dominant dystonia | Q35442453 | ||
| The metabolism of neuronal iron and its pathogenic role in neurological disease: review | Q35754462 | ||
| Neurodegeneration caused by proteins with an aberrant carboxyl-terminus | Q35871644 | ||
| Late onset familial dystonia: could mitochondrial deficits induce a diffuse lesioning process of the whole basal ganglia system? | Q36317027 | ||
| Familial dystonia and choreoathetosis in three generations associated with bilateral striatal necrosis | Q41058061 | ||
| Neuroferritinopathy: a window on the role of iron in neurodegeneration. | Q42436187 | ||
| Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family | Q42485956 | ||
| Palatal tremor and cognitive decline in neuroferritinopathy | Q43045073 | ||
| The striatonigral degenerations. Putaminal pigments and nosology | Q44082200 | ||
| Abnormal iron deposition associated with lipid peroxidation in transgenic mice expressing interleukin-6 in the brain | Q44193172 | ||
| Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene | Q44852329 | ||
| Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers | Q46124789 | ||
| Isoforms of ferritin have a specific cellular distribution in the brain | Q48167065 | ||
| Cytochrome c oxidase deficiency in Leigh syndrome | Q48203324 | ||
| Astrocytic cytoplasmic inclusions within an epileptic focus in an otherwise neurologically intact patient | Q48248259 | ||
| Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies | Q48255664 | ||
| A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains | Q48559600 | ||
| Neurochemical architecture of the human striatum | Q48656419 | ||
| Brain iron and ferritin in Parkinson's and Alzheimer's diseases. | Q53184175 | ||
| P433 | issue | 4 | |
| P921 | main subject | pathology | Q7208 |
| P304 | page(s) | 280-294 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Journal of Neuropathology & Experimental Neurology | Q15716771 |
| P1476 | title | Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights | |
| P478 | volume | 64 |
| Q35926022 | A mutant light-chain ferritin that causes neurodegeneration has enhanced propensity toward oxidative damage. |
| Q50276048 | A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations |
| Q33723799 | A novel ferritin light chain mutation in neuroferritinopathy with an atypical presentation |
| Q36274219 | A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits. |
| Q91518831 | A unique mutation in the L ferritin coding sequence associated with low serum ferritin level in the presence of normal values of other iron parameters |
| Q37054616 | Abnormal iron homeostasis and neurodegeneration |
| Q37226714 | Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene |
| Q34360807 | Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy |
| Q34604521 | Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress |
| Q34036671 | Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy |
| Q37673274 | Basic mechanisms of neurodegeneration: a critical update |
| Q35090866 | Behavioral characterization of mouse models of neuroferritinopathy |
| Q37364099 | Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features |
| Q37605018 | Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities |
| Q34198997 | Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegeneration |
| Q37381544 | Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease. |
| Q43123118 | Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation |
| Q45975097 | Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC). |
| Q47351811 | Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons. |
| Q89927769 | Disorders of metal metabolism |
| Q50721653 | Early neuropsychiatry features in neuroferritinopathy. |
| Q41130164 | Expression and hypoxic up-regulation of neuroglobin in human glioblastoma cells. |
| Q36670692 | Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice |
| Q36852442 | FTL mutation in a Chinese pedigree with neuroferritinopathy |
| Q41836301 | Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA). |
| Q37677839 | Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis? |
| Q31117154 | Iron in chronic brain disorders: imaging and neurotherapeutic implications |
| Q34579454 | Iron loading-induced aggregation and reduction of iron incorporation in heteropolymeric ferritin containing a mutant light chain that causes neurodegeneration |
| Q33248678 | Iron metabolism in Parkinsonian syndromes |
| Q38627193 | Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics |
| Q92534736 | Iron, Ferritin, Hereditary Ferritinopathy, and Neurodegeneration |
| Q30371704 | Iron-mediated aggregation and a localized structural change characterize ferritin from a mutant light chain polypeptide that causes neurodegeneration. |
| Q30530767 | Late-onset neurodegeneration with brain iron accumulation with diffusion tensor magnetic resonance imaging |
| Q39722043 | MRI findings in neuroferritinopathy |
| Q33280572 | Mechanisms of copper ion mediated Huntington's disease progression |
| Q37617682 | MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx |
| Q90074921 | Mutant L-chain ferritins that cause neuroferritinopathy alter ferritin functionality and iron permeability |
| Q24299541 | Mutant ferritin L-chains that cause neurodegeneration act in a dominant-negative manner to reduce ferritin iron incorporation |
| Q64230486 | Neurodegeneration with Brain Iron Accumulation Disorders: Valuable Models Aimed at Understanding the Pathogenesis of Iron Deposition |
| Q21129274 | Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms |
| Q28085033 | Neuroferritinopathy: From ferritin structure modification to pathogenetic mechanism |
| Q26749945 | Neuroferritinopathy: Pathophysiology, Presentation, Differential Diagnoses and Management |
| Q33685685 | Neuroferritinopathy: a new inborn error of iron metabolism |
| Q31076462 | Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach. |
| Q41825693 | Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration |
| Q36381145 | On the complexity of clinical and molecular bases of neurodegeneration with brain iron accumulation |
| Q33685614 | Progressive brain iron accumulation in neuroferritinopathy measured by the thalamic T2* relaxation rate. |
| Q34999535 | Recent advances in our understanding of neurodegeneration |
| Q38203501 | Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis |
| Q36800670 | Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories. |
| Q35049047 | Superoxide dismutases and superoxide reductases |
| Q37949887 | Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations |
| Q38161017 | The neuropathology of neurodegeneration with brain iron accumulation |
| Q98290531 | Treatment of Secondary Chorea: A Review of the Current Literature |
| Q24318488 | Unraveling of the E-helices and disruption of 4-fold pores are associated with iron mishandling in a mutant ferritin causing neurodegeneration |
Search more.